comparemela.com
Latest Breaking News On - Neurimmune ag - Page 1 : comparemela.com
Neurimmune to regain global rights to brain amyloid
Neurimmune aims to develop aducanumab-based therapeutics that can be subcutaneously administered.
Switzerland
Zurich
Züsz
Christoph-hock
Fabian-buller
Chief-medical-officer
Chief-business-officer
Reverse-translational-medicine
Neurimmune-ag
vimarsana © 2020. All Rights Reserved.